The arrestin fold: variations on a theme.

Curr Genomics

CNRS, UMR 5092, 17 rue des Martyrs, Grenoble, 38054, France.

Published: April 2009

Endocytosis of ligand-activated plasma membrane receptors has been shown to contribute to the regulation of their downstream signaling. beta-arrestins interact with the phosphorylated tail of activated receptors and act as scaffolds for the recruitment of adaptor proteins and clathrin, that constitute the machinery used for receptor endocytosis. Visual- and beta-arrestins have a two-lobe, immunoglobulin-like, beta-strand sandwich structure. The recent resolution of the crystal structure of VPS26, one of the retromer subunits, unexpectedly evidences an arrestin fold in this protein, which is otherwise unrelated to arrestins. From a functional point of view, VPS26 is involved in the retrograde transport of the mannose 6-P receptor from the endosomes to the trans-Golgi network. In addition to the group of genuine arrestins and Vps26, mammalian cells harbor a vast repertoire of proteins that are related to arrestins on the basis of their PFAM Nter and Cter arrestin- domains, which are named Arrestin Domain- Containing proteins (ADCs). The biological role of ADC proteins is still poorly understood. The three subfamilies have been merged into an arrestin-related protein clan.This paper provides an overall analysis of arrestin clan proteins. The structures and functions of members of the subfamilies are reviewed in mammals and model organisms such as Drosophila, Caenorhabditis, Saccharomyces and Dictyostelium.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699828PMC
http://dx.doi.org/10.2174/138920209787847014DOI Listing

Publication Analysis

Top Keywords

arrestin fold
8
proteins
5
arrestin
4
fold variations
4
variations theme
4
theme endocytosis
4
endocytosis ligand-activated
4
ligand-activated plasma
4
plasma membrane
4
membrane receptors
4

Similar Publications

Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor.

Bioorg Med Chem Lett

January 2025

Contineum Therapeutics, 3565 General Atomics Court, Suite 200, San Diego, CA 92121, United States.

Novel kappa opioid receptor (KOR) agonists that preferentially activate G-protein signaling versus β-arrestin-2 recruitment are described. Starting from a literature-reported phenol-containing diphenethylamine KOR agonist, structure-activity relationship (SAR) studies revealed replacement of the phenol with various non-hydroxylated bicyclic heteroaromatics led to tertiary diarylethylamines which retained KOR agonist activity and improved metabolic stability in human liver microsomes. Further optimizations produced compound 39, a potent activator of G-protein signaling (GTPγS EC = 14 nM, 83 % E) that did not elicit a β-arrestin-2 recruitment functional response (E < 10 %).

View Article and Find Full Text PDF

A prospective, historical-controlled evaluation of oliceridine for moderate or severe pain in patients with acute burn injuries (RELIEVE).

Burns

November 2024

Department of Pharmacy, Regional One Health, Firefighter's Burn Center, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA.

Oliceridine, a biased, selective opioid agonist, has shown a 3-fold preferential activation of the G-protein (i.e., analgesia) over β-arrestin pathway.

View Article and Find Full Text PDF

Structural basis for Rab6 activation by the Ric1-Rgp1 complex.

Nat Commun

December 2024

Department of Molecular Biology & Genetics and Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, 14850, USA.

Rab GTPases act as molecular switches to regulate organelle homeostasis and membrane trafficking. Rab6 plays a central role in regulating cargo flux through the Golgi and is activated via nucleotide exchange by the Ric1-Rgp1 protein complex. Ric1-Rgp1 is conserved throughout eukaryotes but the structural and mechanistic basis for its function has not been established.

View Article and Find Full Text PDF
Article Synopsis
  • Acute rejection (AR) after heart transplantation is a major complication, prompting this study to explore using ultrasound-targeted microbubbles loaded with sirolimus (SIR-MBs) to improve outcomes in a rat model.
  • The research involved comparing three treatment groups: a control, SIR-MBs with ultrasound targeting, and direct sirolimus, assessing their effects on survival, inflammation, and specific cellular pathways.
  • Results indicated that the SIR-MBs with ultrasound targeting significantly enhanced local drug delivery, reduced inflammatory response, and affected key signaling pathways and autophagy, suggesting a promising method for improving AR treatment in heart transplant patients.
View Article and Find Full Text PDF

Discovery of Potent Kappa Opioid Receptor Agonists Derived from Akuammicine.

J Med Chem

December 2024

Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, Illinois 60612, United States.

Akuammicine (), an alkaloid isolated from , is an agonist of the kappa opioid receptor (κOR). To establish structure-activity relationships (SARs) for this structurally unique κOR ligand, a collection of semisynthetic derivatives was synthesized. Evaluating these derivatives for their ability to activate the κOR and mu opioid receptor (μOR) revealed key SAR trends and identified derivatives with enhanced κOR potency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!